EU medtech sector undergoes rebirth at European MedTech Forum
This article was originally published in Clinica
The European MedTech Forum held in Brussels on 10-12 October marked the launch of the new MedTech Europe alliance between Eucomed and EDMA. Amanda Maxwell attended the meeting and found an industry in flux as it faces the opportunities and challenges of a new era of healthcare
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?
It seems to be game over for anyone who might have been hoping the European Commission would do a U-turn on its decision to use the Italian CND nomenclature as the basis for communication in Eudamed, instead of the well-established GMDN. But GMDN is strong in its resolve to remain a vital global nomenclature service.
2020 is not getting off to a good start for manufacturers needing to comply with the EU’s new Medical Device Regulation on 26 May 2020. The European Commission’s latest document seems to confirm industry’s fears about the ability of the EU’s medtech system to be ready in time.